EAPOC-COPD System for COPD
(EAPOC-COPD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new digital tool called the EAPOC-COPD System, designed to help doctors and nurse practitioners better manage COPD, a lung condition that makes breathing difficult. The tool suggests personalized treatments, checks symptoms, and provides self-care plans based on information shared by patients. The trial will compare care changes with this tool versus traditional methods. It suits patients diagnosed with COPD by a doctor and receiving care at selected sites in Ontario, Canada. The goal is to determine if this tool can improve treatments and overall management of COPD. As an unphased trial, this study offers patients the opportunity to contribute to innovative research that could enhance COPD care for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on optimizing COPD treatment, which might involve changes to your medication, but it doesn't clearly state if you must stop any existing medications.
What prior data suggests that the EAPOC-COPD system is safe for COPD management?
Research has shown that digital tools like the EAPOC-COPD system are generally safe. These tools assist doctors by providing personalized treatment advice based on patient information. Studies have found that similar digital tools receive positive feedback from both patients and healthcare providers. They typically don't cause side effects, as they are neither drugs nor surgeries. Instead, they enhance doctors' ability to make informed treatment decisions and manage diseases like COPD more effectively.
The EAPOC-COPD system collects patient information through a smartphone app or computer and offers treatment suggestions to doctors. This system aims to improve care without introducing new risks. As a digital tool, its safety relies on compatibility with existing health records and user-friendliness. So far, no major safety issues have been reported for systems like EAPOC-COPD.12345Why are researchers excited about this trial?
Researchers are excited about the EAPOC-COPD System because it offers a fresh approach to managing COPD, focusing on early intervention and personalized care. Unlike traditional treatments, which often rely on in-clinic assessments and generalized medication adjustments, this system uses a smartphone or tablet app to gather patient data up to a week before appointments. It then processes this information to provide a tailored risk assessment and COPD action plan, which can be accessed anytime through a patient portal. This proactive and personalized strategy could lead to better symptom management and improved adherence to treatment plans, potentially transforming how COPD care is delivered.
What evidence suggests that the EAPOC-COPD system is effective for COPD management?
Research has shown that digital tools like the EAPOC-COPD system, which participants in this trial may receive, can improve COPD (Chronic Obstructive Pulmonary Disease) management. Studies have found that these systems help doctors adhere more closely to treatment guidelines, leading to better medication choices for COPD patients. A similar system helped patients manage their symptoms and reduced the number of flare-ups. These tools offer personalized action plans and educational resources, which have been linked to improved patient outcomes. By using information reported by patients, these tools customize care more effectively, potentially enhancing overall health and quality of life for those with COPD.56789
Are You a Good Fit for This Trial?
This trial is for COPD patients being treated by providers at six primary care sites in Ontario, Canada. Providers must be using IT infrastructure compatible with the EAPOC-COPD system and caring for COPD patients. Those unwilling to use the EAPOC-COPD system are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention
Sites provide usual care and serve as their own control
Intervention
Transition to EAPOC-COPD-supported care with digital clinical decision support system
Follow-up
Participants are monitored for safety and effectiveness after intervention
What Are the Treatments Tested in This Trial?
Interventions
- EAPOC-COPD System
Trial Overview
The study tests a digital tool called EAPOC-COPD against usual care in managing COPD. It's a stepped wedge cluster randomized controlled trial where each site transitions to the new system over time and serves as its own control before switching.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The EAPOC-COPD system consists of: 1) a smart phone / tablet app or PC-based questionnaire which collects information directly from patients upon prompting, up to 1 week before their clinical appointment; and 2) a point-of-care CDSS that wirelessly receives and processes questionnaire data in order to produce a symptom severity/exacerbation risk assessment, medication change recommendation, and COPD action plan, all of which is made available to providers through a prompt, upon opening the patient chart in the existing EMR. Once approved, the personalized COPD action plan is automatically populated within the patient app/portal, enabling anywhere/anytime access for patients. Patients are also provided with educational resources within their app/portal, designed to improve health literacy, inhaler technique, and adherence to their action plan.
Prior to activation of the EAPOC-COPD system, providers will provide usual care to their patients with COPD
Find a Clinic Near You
Who Is Running the Clinical Trial?
Women's College Hospital
Lead Sponsor
Citations
Study Details | Evaluating the EAPOC-COPD System
There are three types of expanded access: Individual Patients: Allows a single patient, with a serious disease or condition who cannot participate in a clinical ...
2.
trial.medpath.com
trial.medpath.com/clinical-trial/89f0778830ef6938/nct06852339-chronic-obstructive-pulmonary-disease-eapoc-copdEvaluating the EAPOC-COPD System | MedPath
Data Collection: Clinical outcomes will be obtained through chart reviews and data from the Canadian Primary Care Sentinel Surveillance Network (CPCSSN), where ...
Real-world effectiveness study of guideline-directed COPD ...
Real-world effectiveness study of guideline-directed COPD STANDARDized management in patients with chronic obstructive pulmonary disease: a cluster randomised ...
Comparative effectiveness research in chronic obstructive ...
Comparative effectiveness and translational research in chronic obstructive pulmonary disease will require the development of infrastructures to support ...
Digital Service Model for Chronic Obstructive Pulmonary ...
Establishing a digital resource for high-risk COPD patients which contains symptom diaries (structured patient reported outcome questionnaires), integrates ...
NCT06852339 | Evaluating the EAPOC-COPD System
Members are chosen based on the scientific skills and knowledge needed to monitor the particular trial. Also called a data safety and monitoring board, or DSMB.
EAPOC-COPD System for COPD · Info for Participants
Patient-reported outcomes will be captured via questionnaires through the patient app/portal.Sample Size:An estimated 1860 COPD patients will be seen during the ...
Assessment of COPD-related outcomes via a national ...
This review provides an assessment of the methodological and analytical challenges of conducting chronic obstructive pulmonary disease (COPD) outcomes research ...
Long-Term Outcome of Chronic Obstructive Pulmonary ...
This review summarizes the long-term outcomes of patients with COPD. In addition, recent studies on the prediction of adverse outcomes are summarized in the ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.